OECD Series on Adverse Outcome Pathways
An Adverse Outcome Pathway (AOP) describes a logical sequence of causally linked events at different levels of biological organisation, which follows exposure to a stressor and leads to an adverse health effect in humans or wildlife. AOPs are the central element of a toxicological knowledge framework, promoted by member countries through OECD, built to support chemical risk assessment based on mechanistic reasoning. These AOPs are available in the AOP-Wiki, an interactive and virtual encyclopaedia for AOP development. Following their development and review, the endorsed AOPs are published in the OECD Series on Adverse Outcome Pathways. As scientific knowledge progresses, the publication of an AOP in this series does not preclude regular updates or new contributions to a given AOP. While the AOP-Wiki is a dynamic tool, only impactful changes to the AOP will be reflected in subsequent updates of the published AOP.
- ISSN: 2415170X (online)
- https://doi.org/10.1787/2415170X
Adverse Outcome Pathway on Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish)
This AOP details the linkage between binding and activation of androgen receptor (AR) in
females and reductions in cumulative fecundity and spawning. AR-mediated activities are
among the major concerns in endocrine disruptor screening programs. Cumulative
fecundity is the apical endpoint considered in the OECD 229 Fish Short Term Reproduction
Assay. It is also one of several variables with demographic significance in forecasting fish
population trends. Therefore, this AOP supports the use of measures of AR activation as a
means to identify chemicals with potential to adversely affect fish populations. At present,
this AOP is largely supported by evidence from small laboratory model fish species. While
many aspects of the biology underlying this AOP are largely conserved across oviparous
vertebrates, its relevance to vertebrate classes other than fish, or to fish species employing
different reproductive strategies has not been established. Thus, the applicability domain
should be carefully considered when evaluating fit-for-purpose.
- Click to access:
-
Click to download PDF - 2.00MBPDF
-
Click to Read online and shareREAD